Seminars

Webinar recording and handouts

AHPA partnered with the Global Retailer and Manufacturer Alliance (GRMA) to present this free webinar on February 26, 2019 to provide the herbal industry with specific details on the benefits and implementation costs of the new GRMA ANSI-accredited auditing standards.

Recorded January 16, 2019

Effective January 3, 2020, the Office of Environmental Health Hazard Assessment added cannabis (marijuana) smoke and Δ9-tetrahydrocannabinol (Δ9-THC) to the list of chemicals known to the state to cause reproductive toxicity (developmental endpoint) for purposes of California Proposition 65 (Prop 65). At a public meeting on December 11, 2019, the Developmental and Reproductive Toxicant Identification Committee (DARTIC) in its official capacity as the “state’s qualified experts” determined that cannabis (marijuana) smoke and Δ9-tetrahydrocannabinol (Δ9-THC) were shown to cause reproductive toxicity based on the developmental endpoint.

What is AHPA's GACP-GMP guidance and how can it help your business?

Recorded Nov. 30 and Dec. 14

This two-part webinar provides an update on the elements of current Good Manufacturing Practice (cGMP) regulations (21 CFR 111) that have been the primary focus of recent FDA inspections. Experts also provide strategies to respond to an FDA 483 in order to avoid a warning letter.

How to successfully traverse the NDI notification process and avoid common pitfalls

AHPA appreciates the support of its sponsors, but does not endorse, recommend, or provide a warranty for any sponsor company, its products or services. AHPA has no responsibility for any transaction entered into with any of these companies.